Marapharm Ventures Inc (MDM.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 02/28
| 05-2024 | 02-2024 | 11-2023 | 08-2023 | 05-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 278 | 77 | 159 | 220 | 427 |
| Marketable Securities | 84 | 60 | 67 | 104 | 121 |
| Receivables | 12 | 10 | 9 | 14 | 4 |
| TOTAL | $393 | $152 | $245 | $342 | $560 |
| Non-Current Assets | |||||
| PPE Net | 258 | 232 | 1,207 | 1,203 | 1,142 |
| TOTAL | $258 | $232 | $1,207 | $1,203 | $1,142 |
| Total Assets | $651 | $384 | $1,452 | $1,545 | $1,702 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 114 | 134 | 89 | 88 | 12 |
| Accrued Expenses | 61 | 56 | 47 | 41 | 48 |
| TOTAL | $201 | $200 | $153 | $146 | $78 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $201 | $200 | $153 | $146 | $78 |
| Shareholders' Equity | |||||
| Common Shares | 9,054 | 8,749 | 8,858 | 8,858 | 8,858 |
| Retained earnings | -8,791 | -8,751 | -7,746 | -7,645 | -7,454 |
| Other shareholders' equity | 186 | 186 | 186 | 186 | 220 |
| TOTAL | $450 | $185 | $1,298 | $1,400 | $1,624 |
| Total Liabilities And Equity | $651 | $384 | $1,452 | $1,545 | $1,702 |